Kuehn Law Encourages Investors of Axsome Therapeutics, Inc. to Contact Law Firm
Provided By PR Newswire
Last update: Apr 8, 2025
NEW YORK, April 8, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Axsome Therapeutics, Inc. (NASDAQ: AXSM) breached their fiduciary duties to shareholders.
Read more at prnewswire.com
